Guidewire, the insurance software company, has agreed to buy London-based hyperexponential for a base price of $1.7 billion in cash, plus up to $400 million more if specified recurring revenue targets are met, according to the company’s release filed with the SEC on 27 October 2026.
hyperexponential sells AI-native underwriting and pricingsoftware to commercial property and casualty insurers. Guidewire says the platform powers underwriting decisions across more than $75 billion in annual commercial P&C premium.
Video explainer · Guidewire, hyperexponential and this week’s AI deals
A 16:9 video explainer narrated from the published headlines of this piece and three related FourWeekMBA pieces.
The deal in three numbers. Source: Guidewire release (8-K Exhibit 99.1), 27 Oct 2026.
The key insight: As we read it, the deal is priced on recurring revenue: up to $400 million of the consideration depends on “achievement of specified recurring revenue targets,” and Guidewire puts the deal’s value to it in ARR growth, not in a revenue figure for hyperexponential.
The base purchase price is $1.7 billion in cash, “subject to adjustments,” Guidewire said. Up to an additional $400 million of contingent consideration depends on “achievement of specified recurring revenue targets.” At the maximum, that is $2.1 billion, by our arithmetic.
Guidewire expects to fund the deal with $1.0 billion of new term loan financing and existing cash on hand. It said it has a binding debt commitment for the loan from Bank of America and Citibank. The acquisition is expected to close in the second quarter of Guidewire’s fiscal year 2027.
Centerview Partners is Guidewire’s exclusive financial advisor; J.P. Morgan is hyperexponential’s, according to the release.
Guidewire’s base price for hyperexponential ($1.7 billion in cash) and the maximum with the up-to-$400 million contingent payment tied to recurring revenue targets ($2.1 billion, our arithmetic), per Guidewire’s release of 27 October 2026.
What Guidewire Says It Adds
Guidewire expects the deal to contribute at least 650 basis points to its fiscal 2027 ARR growth on an inorganic basis, and at least 150 basis points to its “durable organic ARR growth” after that. It said the deal is expected to have no impact on the first-quarter fiscal 2027 guidance it issued on 3 September, and that it will update full-year guidance on its December earnings call.
The company frames the purchase around what it calls agentic underwriting: “a new approach in which AI agents work alongside underwriters and actuaries to assess risk, price it, and make decisions.” hyperexponential customers named in the release include Aviva, Allianz, Sompo, Beazley, Markel, HDI, Cincinnati Financial, Convex and Bowhead.
“We founded hyperexponential on the conviction that underwriting judgment is the highest-leverage work insurers do,” co-founder and chief executive Amrit Santhirasenan said in the release. Guidewire chief executive Mike Rosenbaum said: “Insurance is a distinctly complex industry, where the quality of risk decisions has an immense impact on business outcomes.”
How hyperexponential Got Here
TechCrunch reported in January 2024 that hyperexponential raised a $73 million Series B led by Battery Ventures, with Highland Europe and Andreessen Horowitz participating, after an $18 million round in 2021. The company told TechCrunch then that it had grown sales ten-fold while remaining profitable. Neither source we read gives a valuation for that round.
As we read it, the buyer is paying for underwriting decisions, not only software seats: Guidewire says hyperexponential powers underwriting decisions across more than $75 billion in annual commercial P&C premium.
As we read it, the funding plan leans on debt: Guidewire expects to fund the deal through $1.0 billion in new term loan financing and existing cash on hand, with a binding debt commitment from Bank of America and Citibank.
As we read it, the 2024 round is the only earlier price signal in the sources we read: TechCrunch reported a $73 million Series B led by Battery Ventures and gave no valuation, so the step-up cannot be computed.
Amrit Santhirasenan, hyperexponential co-founder and chief executive, in Guidewire’s release, 27 October 2026
“We founded hyperexponential on the conviction that underwriting judgment is the highest-leverage work insurers do”
Three Implications
FOR COMMERCIAL INSURERS Guidewire names Aviva, Allianz, Sompo, Beazley, Markel, HDI, Cincinnati Financial, Convex and Bowhead as hyperexponential customers.
FOR GUIDEWIRE’S GUIDANCE Guidewire says it will update full-year fiscal 2027 guidance on its December earnings call, and expects the deal to add at least 650 basis points to fiscal 2027 ARR growth.
FOR AI UNDERWRITING STARTUPS The release values the agreed price at $1.7 billion in cash, with up to $400 million more tied to recurring revenue targets.
The framework puts it this way: “SaaS is charged for access to tools. AGaaS charges for the execution of outcomes.”
As we read it, Guidewire’s own framing fits that line: it describes agentic underwriting as AI agents working alongside underwriters and actuaries “to assess risk, price it, and make decisions.” The framework was published in March 2026 and does not discuss this deal.
What Is Not Established
The release gives no revenue or ARR figure for hyperexponential and no valuation for the 2024 round. The recurring revenue targets behind the $400 million are not specified. The ARR contribution figures are Guidewire’s expectations, not reported results.
This Week In The AI Supercycle
Execution Fault Lines, Concentrated Demand, and Geopolitical Firewalls
This week’s issue: the AI build is not short of demand for its parts. It is short of cheap money, and its end revenue rests on a narrow base of large, often venture-funded buyers.
Guidewire agreed on 27 October 2026 to pay $1.7 billion in cash for hyperexponential, with up to $400 million more tied to recurring revenue targets, and expects to fund it partly with a $1.0 billion term loan.
A note on sourcing. The deal terms, funding plan, ARR expectations and quotations are from Guidewire’s release filed with the SEC on 27 October 2026. The funding history is from TechCrunch’s report of 11 January 2024. The $2.1 billion maximum is our arithmetic. This is not investment advice. We did not contact Guidewire or hyperexponential.
Gennaro Cuofano is a CRO and tech executive who has worked in AI since late 2015, starting with bringing NLP, natural-language generation, voice and chatbot products to the marketing industry. His background is in law and finance: he holds a Master's degree in Law and an International MBA with an emphasis on corporate finance (LUISS Business School and the University of San Diego, 2012), and worked as a financial analyst at a real-estate investment firm in San Diego and as an assistant controller. His work focuses on business model strategy, business engineering and, more broadly, structural analysis: how companies make money, read from their own filings. He created FourWeekMBA and leads research there and at The Business Engineer, his newsletter on AI and business strategy, with over 95,000 subscribers and more than 1,000 published analyses. His writing has also appeared on Entrepreneur (for example, How to Digitize a Family Business in Europe) and HackerNoon. Find him on LinkedIn and Substack. See how we source.
